Related Experiment Videos
Ofloxacin: therapeutic activity in experimental infections
Abstract:
The therapeutic activity of ofloxacin, a new oral fluoroquinolone antibacterial agent, was tested in experimental infections in rodents. Its activity was compared with that of nalidixic acid, norfloxacin, amoxicillin and cotrimoxazole in Pseudomonas aeruginosa pyelonephritis in the rat, and with that of amikacin and cefotaxime in Proteus morganii thigh infections in mice. Ofloxacin proved to be more effective than reference drugs, even if parenterally administered, in reducing the bacterial count in muscle, kidney and urine.
Insights
Ofloxacin, a new fluoroquinolone antibiotic, demonstrated superior therapeutic activity against bacterial infections in rodent models. It effectively reduced bacterial counts in key tissues and urine compared to other tested antibiotics.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Ofloxacin is an emerging oral fluoroquinolone antibiotic.
- Antibiotic resistance necessitates the evaluation of new therapeutic agents.
Purpose of the Study:
- To evaluate the therapeutic efficacy of ofloxacin in experimental rodent infection models.
- To compare ofloxacin's activity against established antibiotics.
Main Methods:
- Experimental rodent models were used to induce infections.
- Ofloxacin's efficacy was assessed in rat pyelonephritis (Pseudomonas aeruginosa) and mouse thigh infections (Proteus morganii).
- Bacterial counts in tissues (muscle, kidney) and urine were quantified.
Main Results:
- Ofloxacin exhibited greater effectiveness than comparator drugs in reducing bacterial loads.
- This enhanced activity was observed across muscle, kidney, and urine samples.
- Ofloxacin demonstrated efficacy even when administered parenterally.
Conclusions:
- Ofloxacin shows significant therapeutic potential as an antibacterial agent.
- Its efficacy surpasses that of several reference antibiotics in the studied models.
- Ofloxacin represents a promising option for treating specific bacterial infections.